Celldex Therapeutics Long Term Debt 2010-2022 | CLDX
Celldex Therapeutics long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
Celldex Therapeutics Annual Long Term Debt (Millions of US $) |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
2016 |
$ |
2015 |
$ |
2014 |
$ |
2013 |
$ |
2012 |
$6 |
2011 |
$9 |
2010 |
$9 |
2009 |
$12 |
Celldex Therapeutics Quarterly Long Term Debt (Millions of US $) |
2022-03-31 |
|
2021-12-31 |
|
2021-09-30 |
|
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
|
2018-06-30 |
|
2018-03-31 |
|
2017-12-31 |
|
2017-09-30 |
|
2017-06-30 |
|
2017-03-31 |
|
2016-12-31 |
|
2016-09-30 |
|
2016-06-30 |
|
2016-03-31 |
|
2015-12-31 |
|
2015-09-30 |
|
2015-06-30 |
|
2015-03-31 |
|
2014-12-31 |
|
2014-09-30 |
|
2014-06-30 |
|
2014-03-31 |
|
2013-12-31 |
|
2013-09-30 |
|
2013-06-30 |
|
2013-03-31 |
$4 |
2012-12-31 |
$6 |
2012-09-30 |
$7 |
2012-06-30 |
$9 |
2012-03-31 |
$10 |
2011-12-31 |
$9 |
2011-09-30 |
$11 |
2011-06-30 |
$10 |
2011-03-31 |
$12 |
2010-12-31 |
$9 |
2010-09-30 |
|
2010-06-30 |
|
2010-03-31 |
|
2009-12-31 |
$12 |
2009-09-30 |
$1 |
2009-06-30 |
$1 |
2009-03-31 |
$1 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$1.061B |
$0.005B |
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
|